CLIO Cosmetics Co.,Ltd (KOSDAQ:237880)

Market Cap	257.61B
Revenue (ttm)	340.73B
Net Income (ttm)	20.44B
Shares Out	17.52M
EPS (ttm)	1,166.30
PE Ratio	12.60
Forward PE	9.68
Dividend	400.00 (2.72%)
Ex-Dividend Date	Dec 27, 2024

Volume	50,269
Average Volume	115,242
Open	14,400
Previous Close	14,300
Day's Range	14,220 - 14,460
52-Week Range	14,250 - 35,950
Beta	0.61
RSI	32.12
Earnings Date	Aug 5, 2025

About Revance Therapeutics

CLIO Cosmetics Co.,Ltd provides makeup products in South Korea and internationally. It offers eye liner and brow, cushion, lipstick, lip tint, shading, skincare, hair, as well as body and perfumes. The company offers its products under the CLIO, peripera, goodal, DERMATORY, Healing Bird, etc. brands through its CLUB CLIO shopping mall, as well as provides professional services through offline stores and online malls. CLIO Cosmetics Co.,Ltd was founded in 1993 and is based in Seoul, South Korea.

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 1993
• Employees: 338
• Stock Exchange: KOSDAQ
• Ticker Symbol: 237880

Financial Performance

In 2024, CLIO Cosmetics Co.,Ltd's revenue was 351.37 billion, an increase of 6.29% compared to the previous year's 330.58 billion. Earnings were 27.86 billion, an increase of 0.61%.